These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 9067270

  • 1. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 2. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

  • 3. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J, Isaacs JT.
    Cancer Res; 1995 Aug 15; 55(16):3517-20. PubMed ID: 7543015
    [Abstract] [Full Text] [Related]

  • 4. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G.
    Clin Cancer Res; 2000 Sep 15; 6(9):3739-47. PubMed ID: 10999768
    [Abstract] [Full Text] [Related]

  • 5. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
    Sugamoto T, Tanji N, Sato K, Fujita H, Nishio S, Sakanaka M, Yokoyama M.
    Anticancer Res; 2001 Sep 15; 21(1A):77-88. PubMed ID: 11299793
    [Abstract] [Full Text] [Related]

  • 6. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP.
    Clin Cancer Res; 1999 Apr 15; 5(4):783-9. PubMed ID: 10213213
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts.
    Stewart RJ, Panigrahy D, Flynn E, Folkman J.
    J Urol; 2001 Feb 15; 165(2):688-93. PubMed ID: 11176459
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL.
    Prostate; 2002 Aug 01; 52(3):173-82. PubMed ID: 12111694
    [Abstract] [Full Text] [Related]

  • 10. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD, Shi YX, Im SA, Chen X, Yung WK.
    Clin Cancer Res; 2000 Jun 01; 6(6):2562-72. PubMed ID: 10873113
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK, Halsør EF.
    Cancer Res; 2000 Sep 01; 60(17):4932-8. PubMed ID: 10987309
    [Abstract] [Full Text] [Related]

  • 12. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.
    Joseph IB, Vukanovic J, Isaacs JT.
    Cancer Res; 1996 Aug 01; 56(15):3404-8. PubMed ID: 8758902
    [Abstract] [Full Text] [Related]

  • 13. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
    Fang J, Yan L, Shing Y, Moses MA.
    Cancer Res; 2001 Aug 01; 61(15):5731-5. PubMed ID: 11479208
    [Abstract] [Full Text] [Related]

  • 14. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
    Cheng L, Zhang S, Sweeney CJ, Kao C, Gardner TA, Eble JN.
    Anticancer Res; 2004 Aug 01; 24(4):2135-40. PubMed ID: 15330153
    [Abstract] [Full Text] [Related]

  • 15. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF.
    Cancer Res; 1996 Jan 01; 56(1):172-81. PubMed ID: 8548760
    [Abstract] [Full Text] [Related]

  • 16. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L, Lucci JA, Pazdrak B, Cheng JZ, Guo YS, Townsend CM, Hellmich MR.
    Cancer Res; 2003 Jul 01; 63(13):3495-502. PubMed ID: 12839933
    [Abstract] [Full Text] [Related]

  • 17. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes.
    Huang YQ, Li JJ, Hu L, Lee M, Karpatkin S.
    Thromb Haemost; 2001 Oct 01; 86(4):1094-8. PubMed ID: 11686329
    [Abstract] [Full Text] [Related]

  • 18. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE.
    Cancer Res; 2000 Jul 01; 60(13):3655-61. PubMed ID: 10910082
    [Abstract] [Full Text] [Related]

  • 19. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U, Rodeck U, Karpinski S, Jost M, Philippou S, Schmiegel W.
    Cancer Res; 2001 Oct 01; 61(19):7282-90. PubMed ID: 11585767
    [Abstract] [Full Text] [Related]

  • 20. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
    Li X, Liu X, Wang J, Wang Z, Jiang W, Reed E, Zhang Y, Liu Y, Li QQ.
    Anticancer Res; 2003 Oct 01; 23(3B):2481-7. PubMed ID: 12894531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.